Trent JC - Search Results

1

Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers.

Madariaga A, Rustin GJS, Buckanovich RJ, Trent JC, Oza AM. Madariaga A, et al. Among authors: trent jc. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e152-e166. doi: 10.1200/EDBK_238755. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099646 Free article. Review.

2

The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.

Mahmoud O, Dosch A, Kwon D, Pitcher JD, Conway S, Benedetto P, Fernandez G, Trent J, Temple HT, Wolfson AH. Mahmoud O, et al. Am J Clin Oncol. 2016 Oct;39(5):528-34. doi: 10.1097/COC.0000000000000087. Am J Clin Oncol. 2016. PMID: 24879472

3

The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.

Tinoco G, Wilky BA, Paz-Mejia A, Rosenberg A, Trent JC. Tinoco G, et al. Among authors: trent jc. Am Soc Clin Oncol Educ Book. 2015:e648-55. doi: 10.14694/EdBook_AM.2015.35.e648. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993236 Free article. Review.

4

Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma.

Baldini EH, Le Cesne A, Trent JC. Baldini EH, et al. Among authors: trent jc. Am Soc Clin Oncol Educ Book. 2018 May 23;38:910-915. doi: 10.1200/EDBK_201421. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231383 Free article. Review.

5

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.

6

Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients.

Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Dumont SN, et al. Among authors: trent jc. Cancer Med. 2013 Aug;2(4):553-63. doi: 10.1002/cam4.92. Epub 2013 Jul 15. Cancer Med. 2013. PMID: 24156028 Free PMC article.

7

Managing GIST in the imatinib era: optimization of adjuvant therapy.

Trent JC, Subramanian MP. Trent JC, et al. Expert Rev Anticancer Ther. 2014 Dec;14(12):1445-59. doi: 10.1586/14737140.2014.952284. Epub 2014 Oct 23. Expert Rev Anticancer Ther. 2014. PMID: 25340579 Review.

8

Current status of immunotherapy for gastrointestinal stromal tumor.

Tan Y, Trent JC, Wilky BA, Kerr DA, Rosenberg AE. Tan Y, et al. Among authors: trent jc. Cancer Gene Ther. 2017 Mar;24(3):130-133. doi: 10.1038/cgt.2016.58. Epub 2017 Feb 10. Cancer Gene Ther. 2017. PMID: 28186088 Review.

9

Latest advances in adult gastrointestinal stromal tumors.

Florou V, Wilky BA, Trent JC. Florou V, et al. Among authors: trent jc. Future Oncol. 2017 Oct;13(24):2183-2193. doi: 10.2217/fon-2017-0245. Epub 2017 Oct 6. Future Oncol. 2017. PMID: 28984483 Review.

10

Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.

Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP. Raut CP, et al. JAMA Oncol. 2018 Dec 1;4(12):e184060. doi: 10.1001/jamaoncol.2018.4060. Epub 2018 Dec 13. JAMA Oncol. 2018. PMID: 30383140 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page